Novo Nordisk’s Ozempic, also known as semaglutide, is a drug generally used to treat type-2 diabetes. However, the market for Ozempic is facing major shortages in supply globally due to
We are pleased to share that our founder Adv. Biswajit Sarkar has been invited to be a Keynote Speaker at the Conference- “IP Eurasia/IP India’23” conducted by the Eurasian Patent